Send Message
Home News

company news about Progress in development of coVID-19 vaccine

Certification
China Shandong Yihua Pharma Pack Co., Ltd. certification
China Shandong Yihua Pharma Pack Co., Ltd. certification
Customer Reviews
Amazing company.I'm very satisfied.

—— Michael Wozney

Professional service and excellent quality product.Exactly as described, professional service and communication.

—— Lee Rogers Rogers

Great Service and product!

—— Paul M

Very good. I like them,including people and products!

—— max Kratos

I'm Online Chat Now
Company News
Progress in development of coVID-19 vaccine
Latest company news about Progress in development of coVID-19 vaccine

    COVID-19 regular press conference was held by World Health Organization (WHO) on August 6th, Michael J Ryan, the director of World Health Organization (WHO)'s health emergency project, said that there are about 165 vaccines in the trial stage worldwide. 26 kinds of them are in clinical trials, and 6 kinds of them have been in phase III clinical trials, three of which are from China, and it is incredible to achieve such results in a short period of time. The next step is to ensure the safety and effectiveness of the vaccine. Large-scale trials will be conducted in Phase III clinical trials. World Health Organization (WHO) hopes that more vaccine candidates will enter the phase III clinical trials.

 

    

We are a professional manufacturer of glass vaccine bottles.

We have more than 20 years glass bottle production experience.

The specification of the product has 2ml 3ml 5ml 7ml 10ml; Other specifications can also be customized.

The material of glass is mainly neutral borosilicate glass,Its water resistance can reach type I.

We have GMP(ISO15378), FDA(DMF:034963), CE, ISO9001, ISO14001.

latest company news about Progress in development of coVID-19 vaccine  0

Pub Time : 2020-08-07 13:15:07 >> News list
Contact Details
Shandong Yihua Pharma Pack Co., Ltd.

Contact Person: Ms. Sophia

Tel: 86-18553136161

Fax: 86-0531-88160903

Send your inquiry directly to us (0 / 3000)